D.E. Shaw & Co’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,859
| Closed | -$41.5K | – | 3270 |
|
|
2025
Q1 | $41.5K | Sell |
3,859
-44,454
| -92% | -$478K | ﹤0.01% | 2895 |
|
|
2024
Q4 | $618K | Buy |
48,313
+24,682
| +104% | +$316K | ﹤0.01% | 2312 |
|
|
2024
Q3 | $652K | Buy |
23,631
+3,588
| +18% | +$99K | ﹤0.01% | 2365 |
|
|
2024
Q2 | $581K | Buy |
20,043
+1,363
| +7% | +$39.5K | ﹤0.01% | 2422 |
|
|
2024
Q1 | $833K | Buy |
+18,680
| New | +$833K | ﹤0.01% | 2194 |
|
|
2023
Q2 | – | Sell |
-818
| Closed | -$38.6K | – | 3235 |
|
|
2023
Q1 | $38.6K | Sell |
818
-2,175
| -73% | -$103K | ﹤0.01% | 2967 |
|
|
2022
Q4 | $208K | Sell |
2,993
-2,369
| -44% | -$164K | ﹤0.01% | 3020 |
|
|
2022
Q3 | $786K | Sell |
5,362
-8,080
| -60% | -$1.18M | ﹤0.01% | 2663 |
|
|
2022
Q2 | $1.75M | Sell |
13,442
-2,720
| -17% | -$355K | ﹤0.01% | 2344 |
|
|
2022
Q1 | $1.63M | Buy |
16,162
+8,058
| +99% | +$814K | ﹤0.01% | 2570 |
|
|
2021
Q4 | $1.25M | Buy |
+8,104
| New | +$1.25M | ﹤0.01% | 2629 |
|